Germany Daily Briefing

SAP's single-session gain of 4.75% stands out in a session where the rest of the DAX bled lower. The read: institutional money is rotating from cyclical export names (autos, chemicals, semis) into enterprise software — the one segment of the German market with USD-denominated revenue growth stories. SAP's RISE with SAP migration pipeline and growing AI-native module adoption give it a credible agentic AI narrative that's drawing capital from the US tech rotation into European software proxies.

FAZ cites BIS economist Frank Smets noting that even with the Strait of Hormuz technically open, ongoing geopolitical pressure continues to push energy costs higher — a direct read-through for Germany's energy-intensive industrial sector. BASF and other chemical heavyweights face elevated feedstock costs; the energy transition (Energiewende) capex doesn't replace fossil input costs overnight. Infineon's -4.5% decline may partly reflect this energy cost anxiety flowing into semiconductor fab operating margins.

FAZ analysis following the recent Bayer glyphosate ruling suggests the stock has further room to run — a contrarian call that's worth framing carefully. Bayer's litigation liability has been a multi-year overhang on the MDAX; any court ruling clarity removes a tail risk that was keeping re-rating investors on the sidelines. If FAZ's read holds, Bayer could be the MDAX's most asymmetric trade heading into H2 2026.